Enhanced CD8+ T cell immunity against HCV in HCV/HIV coinfected individuals is likely to accelerate liver disease, while those who acquire HCV following the generalized decline in cellular immunity associated with progressive HIV infection are likely to have especially weak HCV-specific cellular immunity. Here, CD8A is linked to HIV infectious disease.